JOSHUA WILSON: Open Payments
NPI 1609130061 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,734 in 320 payments from 21 companies in 2025. Trend: 2023 $4,247 · 2024 $3,587 · 2025 $4,734
Food & beverage: $4,690Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 58 | $825 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 36 | $605 |
| Otsuka America Pharmaceutical, Inc. | 40 | $463 |
| Axsome Therapeutics, Inc. | 23 | $460 |
| Corium, LLC | 28 | $414 |
| Alkermes, Inc. | 20 | $315 |
| Vanda Pharmaceuticals Inc. | 24 | $258 |
| E.R. Squibb & Sons, L.L.C. | 18 | $232 |
| Neurocrine BioSciences, Inc. | 15 | $221 |
| Lundbeck LLC | 10 | $170 |
Products named: VRAYLAR, CAPLYTA, REXULTI, Auvelity, Azstarys, ARISTADA, FANAPT, COBENFY.
Industry payments across MO — which companies pay providers there.
